KPV (Lys-Pro-Val) | Tripeptide Anti-Inflammatory Research

KPV (Lys-Pro-Val): The Non-Melanotropic Anti-Inflammatory Tripeptide

The Biochemistry of KPV (Lys-Pro-Val)

KPV (Lys-Pro-Val) consists of the amino acid sequence Lysine-Proline-Valine. While $\alpha$-MSH is a larger 13-amino acid peptide, the anti-inflammatory “signal” is concentrated in this small tripeptide fragment. Its small molecular size allows for exceptional bioavailability and the ability to cross cellular membranes effectively. Unlike many peptides, KPV (Lys-Pro-Val) is highly stable, making it a versatile subject for both topical and systemic research models.

Mechanism of Action: NF-κB Inhibition and Mast Cell Stabilization

In advanced immunology and cellular biology, KPV (Lys-Pro-Val) functions through several targeted pathways:

1. Inhibition of NF-κB Signaling: KPV (Lys-Pro-Val) is studied for its ability to enter cells and block the activation of Nuclear Factor-kappa B (NF-κB). By preventing this transcription factor from entering the nucleus, the peptide inhibits the production of pro-inflammatory cytokines like IL-1β, IL-6, and TNF-α.

2. Mast Cell Stabilization: Research suggests that KPV (Lys-Pro-Val) can prevent mast cells from degranulating, which reduces the release of histamine and proteases involved in allergic and inflammatory responses.

3. Antimicrobial Properties: The peptide is investigated for its direct antimicrobial effects, particularly against Staphylococcus aureus and Candida albicans, by disrupting the pathogen’s metabolic processes.

4. Intestinal Mucosal Healing: In enteric research, KPV (Lys-Pro-Val) is observed to upregulate the expression of tight junction proteins and reduce the “leakage” associated with intestinal inflammation.

Primary Research Applications of KPV (Lys-Pro-Val)

• Inflammatory Bowel Disease (IBD) Models: Analyzing the reduction of colonic inflammation and the promotion of mucosal recovery.

• Dermatological Research: Investigating the treatment of psoriasis, dermatitis, and acne through the suppression of localized immune overactivity.

• Mast Cell Activation Syndrome (MCAS): Studying the stabilization of histamine release in sensitive research models.

• Wound Healing: Observing the acceleration of skin repair and the reduction of excessive scar tissue (fibrosis).

4. Technical Specifications (E-E-A-T Data)

5. Product FAQ 

Q: Does KPV (Lys-Pro-Val) cause skin tanning?

A: No. While KPV (Lys-Pro-Val) is a fragment of Alpha-MSH, it does not contain the sequence responsible for binding to the Melanocortin 1 Receptor (MC1R). Therefore, it does not stimulate melanin production or cause tanning in research subjects.

Q: Why is KPV (Lys-Pro-Val) preferred for gut research?

A: Its extremely small molecular weight (342.43 g/mol) and stability allow it to be absorbed efficiently by the intestinal lining. Research focuses on its ability to act directly on the enterocytes to shut down inflammatory signaling from within the gut wall.